AYTU BIOPHARMA, INC 10-K filing
Filed 2025-09-23 · Report date 2025-06-30 · 2025 FY
Filing metadata
- Accession number
- 0001437749-25-029723
- Form type
- 10-K
- CIK
- 0001385818
- Primary document
- https://www.sec.gov/Archives/edgar/data/1385818/000143774925029723/aytu20250630c_10k.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for AYTU BIOPHARMA, INC.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $66.4M | - | - |
| Cost Of Revenue | $20.6M | - | - |
| Gross Profit | $45.8M | - | - |
| Operating Income | $-7.8M | - | - |
| Net Income | $-13.6M | - | - |
| Eps Basic | -2.16 | - | - |
| Cash And Equivalents | $31.0M | - | - |
| Total Assets | $124.2M | - | - |
| Shareholders Equity | $19.0M | - | - |
| Operating Cash Flow | $-1.9M | - | - |
| Capital Expenditures | $228,000 | - | - |